THAI NVDR CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.25 THB | -0.59% |
|
-3.98% | +0.60% |
| Sales 2024 * | 3.05B 82.87M | Sales 2025 * | 3.9B 106M | Capitalization | 9.3B 253M |
|---|---|---|---|---|---|
| Net income 2024 * | 361M 9.81M | Net income 2025 * | 442M 12.01M | EV / Sales 2024 * | 3.05 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.39 x |
| P/E ratio 2024 * |
25.8
x | P/E ratio 2025 * |
21
x | Employees | - |
| Yield 2024 * |
2.71% | Yield 2025 * |
3.18% | Free-Float | 24.62% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.59% | ||
| 1 week | -3.98% | ||
| Current month | -4.52% | ||
| 1 month | -0.59% | ||
| 3 months | +5.62% | ||
| 6 months | -1.17% | ||
| Current year | +0.60% |
1 week
41.00
45.25
1 month
40.2545.25
Current year
36.2545.25
1 year
34.5045.25
3 years
31.5047.25
5 years
31.5047.25
10 years
31.5047.25
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 16-06-28 | |
| Director of Finance/CFO | - | 23-04-22 | |
| Chief Operating Officer | 40 | 22-11-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Viboon Pojanalai
BRD | Director/Board Member | 49 | 21-01-18 |
| Chief Executive Officer | - | 16-06-28 | |
| Chief Operating Officer | 40 | 22-11-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-02 | 42.25 | -0.59% | 1,021,460 |
| 24-07-01 | 42.5 | -3.95% | 1,870,487 |
| 24-06-28 | 44.25 | -1.12% | 1,205,000 |
| 24-06-27 | 44.75 | 0.00% | 1,676,817 |
| 24-06-26 | 44.75 | +1.70% | 1,283,902 |
End-of-day quote Thailand S.E., July 01, 2024
More quotes
The Klinique Medical Clinic PCL is a Thailand-based company, which is principally engaged in providing medical treatment services regarding skin and selling cosmetics and cosmeceutical under the name of The Klinique. The Company is engaged in covering all skin and body problems, such as Ulthera SPT+, ThermageFLX Pro, Pico Clear Enlighten, CopperBromide, eLos Plus, eMatrix, New YAG Laser or liposuction, such as New Coolsculpting, VelaShape III, Emsculpt NEO, VASER, and BodyTite, as well as anti-aging medicine and women wellness. The Company's services include facelift, acne, acne scars, acne scars, shape up, Filler, Fat dissolving injections, laser hair removal, skin injection, Mesoface, meso, nose surgery, eye surgery, and facial surgery.
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.25
THB
Average target price
54.83
THB
Spread / Average Target
+29.78%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.60% | 252M | |
| -35.02% | 13.14B | |
| +4.48% | 11.75B | |
| -6.31% | 11.22B | |
| +7.51% | 10.5B | |
| +28.25% | 8.62B | |
| -11.39% | 7.09B | |
| +12.23% | 7.11B | |
| +7.33% | 6.4B | |
| 0.00% | 4.24B |
- Stock Market
- Equities
- KLINIQ Stock
